To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
This study is a phase 3 study,to evaluate the efficacy and safety of different doses of JAK1 inhibitor SHR0302 in subjects with active psoriatic arthritis.
Epistemonikos ID: 6511be2a09c677915c5a5003d19b10583072254f
First added on: Feb 15, 2022